Myriad Genetics, Inc. (MYGN) Financials

MYGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 673.7 million 336.3 million
Dec. 31, 2025 706.6 million 338.6 million
Sept. 30, 2025 728.1 million 355.3 million
June 30, 2025 677.3 million 289.2 million

MYGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -21.1 million 6.5 million
Dec. 31, 2025 5.9 million 2.8 million
Sept. 30, 2025 14.9 million 12.2 million
June 30, 2025 -20.5 million 10.7 million

MYGN Net Income

No data available :(

MYGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 124.4 million 204.4 million 91.2 million
Dec. 31, 2025 149.6 million 202.9 million 89.9 million
Sept. 30, 2025 145.4 million 119.5 million 92.8 million
June 30, 2025 74.4 million - 95.2 million

MYGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 93.7 million
Dec. 31, 2025 93.3 million
Sept. 30, 2025 93.1 million
June 30, 2025 92.5 million

MYGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.4 million 27.1 million 135.8 million 73.6 million
Dec. 31, 2025 4.7 million 25.5 million 124.3 million 68.7 million
Sept. 30, 2025 6.2 million 28.2 million 138.9 million 71.0 million
June 30, 2025 6.9 million 25.6 million 138.7 million 71.9 million

MYGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 200.4 million 62.8 million
Dec. 31, 2025 209.8 million 63.0 million
Sept. 30, 2025 205.7 million 61.9 million
June 30, 2025 213.1 million 61.3 million

MYGN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MYGN

Price: $4.40

52 week price:
3.55
8.59

Payout Ratio Range:
-983.33%
701.27%

Earnings Per Share: -4.31 USD

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 315100

Ebitda: 17.5 million

Market Capitalization: 397.6 million

Links: